PMO PMO
Company Profile ↓Company Overview
PMO (PMO) is a publicly traded company listed on with a market capitalization of $267.42M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 40.2% per year over the last five years.
Revenue has grown at a 39.0% CAGR over the past five years.
Maintains a net profit margin of 99.6%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Apr 2026 Revenue of $29.61M (+175.4% YoY); net profit $29.49M.
- Trailing 12 Months Year-on-year growth — revenue +175.4%, earnings +175.9%.
- 5-Year Trend Long-term compounding — revenue CAGR 39.0%, profit CAGR 40.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 38.95% |
| 1 Year: | 175.37% |
Compounded Profit Growth
| 5 Years: | 40.21% |
| 1 Year: | 175.91% |
Stock Price Performance
| 1 Year: | -1.59% |
| 6 Months: | -3.86% |
| 3 Months: | -4.34% |
| 1 Month: | +5.29% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)56.49 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 99.6%.
- Compounding revenue at 39.0% over 5 years.
- Profit CAGR of 40.2% over 5 years.
- Generates positive free cash flow.
CONS
- Trading at a high P/E of 244.0.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | Apr 2026 |
|---|---|---|---|---|---|
| Revenue | - | 11.04M | 19.08M | 10.75M | 29.61M |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 337.35K | 78.69K | 64.38K | 120.20K |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | - | 1.39M | 635.58K | 421.25K | 617.42K |
| Pretax Income | - | 10.70M | 19.00M | 10.69M | 29.49M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | 10.70M | 19.00M | 10.69M | 29.49M |
| Diluted EPS | -1.68 | 0.31 | 0.59 | 0.04 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | Apr 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 549.39M | 498.05M | 457.56M | 473.38M |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | 608.61K | - | - | 72.27K | - |
| Inventory | - | - | - | - | - |
| Receivables | - | 7.43M | 9.18M | 6.40M | 7.50M |
| Total Liabilities | - | 33.25M | 12.38M | 12.35M | 25.18M |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 21.41M | 7.58M | 10.21M | 21.91M |
| Total Equity | - | 516.14M | 485.67M | 445.22M | 448.20M |
| Shares Outstanding | - | 33.78M | 31.06M | 28.06M | 27.40M |
Cash Flows (Annual)
Figures in USD.
| Metric | Apr 2022 | Apr 2023 |
|---|---|---|
| Operating Cash Flow | 25.10M | 62.70M |
| Investing Cash Flow | - | - |
| Financing Cash Flow | -24.50M | -63.38M |
| Capital Expenditure | - | - |
| Free Cash Flow | 25.10M | 62.70M |
| Net Change in Cash | 600.54K | -677.55K |
Ratios (Annual)
Figures in %.
| Metric | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | Apr 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | 96.9% | 99.6% | 99.4% | 99.6% |
| ROE % | - | 2.1% | 3.9% | 2.4% | 6.6% |
| ROCE % | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for PMO
FRANKLIN MUNICIPAL OPPORTUNITIES TRUST SEC Filing (Oct 9, 2026) - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNZGh2R3BtYTdFeks2aWdSZ0ZuUEJUS1RCejI4TUhZY3YxWk1PM3lBS0JkbzQ1aFJBd1VTM1NTZlJxZVloaTRrejZLQk1IdTYxYjlRdGViQkF0UkdMX2tpb2FxbDBpVXpFS0dYcFdSb295cFBWd0RnVzBiRWxCVDZja3VhUXdjbGJUTms0ck…
Precision Trading with Putnam Municipal Opportunities Trust (PMO) Risk Zones - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMi6gFBVV95cUxQc0gxTDdoaFY0SkppTENpajRrQzRRR0RXSXBMaDlTNE5nYXdYZWhBMlpkMzNPY3lVRk1DQUM1OEJpcEE3MDlVVzEzYkY0OURwdWU1cjVlLUpDRjdrTW5hdzBZQUJMWnFtbFZlajZvRHlSMzZLMndaSVJjdkhWc3JRRzFyMzdCQko5SDU5V0…
PMO takes stock of El Nino impact, monitoring level & preparedness - The Indian Express
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxPN2tXUWtMbzBSOEhMR29JUzNiWlRZeWMtb19FUHZpRTdTSEFuNW5VVVIxNGRENXp1M0kxOGU1dklhektmR0M0dXV2RWh1cnpONTIwc2psWGdUSHFJSWZYSDk3Y04ybkEtcHlMd2hMM3VBeGlIaXc2TjNHbXBFTGxNNkFKZHAwVVBWRHBtTG…
PMO Fake ID Case: Police Question Accused's Father, A Stockbroker, For Three Hours - NDTV Profit
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxQNGNENXlDNXI1U0FfcDZpSjJoS191dE90bTM0aHFTcWhZdUZ6YXYzdjN5Y3NkU3N2dThDX1hydkVfYVczOFRxOTFHTF81ZXFnMDFqWlFab010SG5fNEVxWEtpRFZkdkpTTUpWa0dLUnJ4LUJZNTVvZnZ6a2tYLTdMbDdnb2dsNVJsNHJ4RD…
Putnam Municipal Opportunities Trust (PMO) Shows Slight Decline Amid Steady Trading - Breakout Confirmation - www.dars.gov.et
<a href="https://news.google.com/rss/articles/CBMi-gFBVV95cUxQb0RKc0dHNGw2dWRkeDJFQ3Z4RmtybWVBRzJoOFJmSVFKazlSUVIzZGdkUEpvMzhZWGdWVEhtT2xRR0YzZl9FLVBzUzNpZW5WWFo3Rldzby0zWWRIYl9iYzY3YUt2anhqVTFhWVd5V3B0d3F4ZVA3WjZLc041S0RxT0xhdjlKY0lZYkU5Rz…
Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE - Sarepta Therapeutics
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxPUmJxUHVieEoyNFZhNmdFXzg2SURVYUJBcUI1NVpHTjU5RGZwanJZRmd1R3hWRXNnTXlTOWhHOGJUWUMxQmt2WGFyWEQ4VFBoT1lGdHUxNjBQeXpPejBTQnRkWEhtTm1mUjR4ZG5YVXJWSGRRYnp6RTVrZzVwelQ4blJWRWpFQjczTUVWQ2…
PMO — Frequently Asked Questions
What is the current share price of PMO?
As of 2026-10-23 16:27 PDT, PMO trades at $9.76 on NASDAQ/NYSE. Its 52-week range is $9.06 to $10.62.
What is the market capitalisation of PMO?
PMO has a market capitalisation of $267.42M on NASDAQ/NYSE.
What is the P/E ratio of PMO?
PMO trades at a trailing price-to-earnings (P/E) ratio of 244.00. Its price-to-book (P/B) ratio is 0.60.
What is the return on equity (ROE) of PMO?
PMO has a return on equity (ROE) of 6.58%.
Is PMO a good stock to buy?
This page provides a data-driven analysis of PMO, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.